We are changing the paradigm of cancer therapy with our immunotherapy technology. 

Our science

Our focus is on using bispecific antibody approaches.

Read more

Platform and application

NovalGen is developing a platform approach to innovation. Our know-how and technology enable us to mimic the function of multifaceted antibodies.

Read more